Company Insights

AIXI supplier relationships

Explore interactive graphBrowse insights index
AIXI supplier relationship map

AIXI (Xiao‑I): Supplier relationships that matter for investors evaluating counterparty risk

Xiao‑I Corporation (AIXI) builds and sells enterprise AI software and smart‑city solutions in China and monetizes through software licensing, AI services, and commercial deployments via its subsidiary Shanghai Xiaoi Robot Technology. Revenue is generated primarily from recurring software/service contracts and large institutional deals; public market capital formation (IPO underwriting and listings) is the one‑off financing channel that shaped its current ownership and disclosure profile. For investors and operators assessing supplier and capital markets counterparties, the relevant relationships are concentrated around the underwriting syndicate that carried the company into U.S. markets. Learn more about supplier relationship intelligence at https://nullexposure.com/.

Quick take: the commercial reality behind the headlines

Xiao‑I is a small‑cap, loss‑making software company with a revenue base (TTM revenue ~$70.3M) and persistent negative earnings (TTM diluted EPS -1.68; negative EBITDA). This profile produces two operating realities: first, capital markets relationships (underwriters) are strategic for liquidity and credibility; second, vendor and customer contracting posture will be driven by short payback expectations and tight margin control. For deeper supplier and underwriting exposure analysis visit https://nullexposure.com/.

Who shows up in the public record: all relationships from the review

Below I walk through every supplier/partner mention surfaced in public coverage tied to AIXI’s capital markets activity. Each entry is drawn from Renaissance Capital reporting on Xiao‑I’s IPO process.

Prime Number Capital — (Renaissance Capital news, March 2026)

Prime Number Capital is listed as a joint bookrunner on Xiao‑I’s U.S. IPO, establishing it as a primary capital markets counterparty involved in pricing and distribution of the offering. According to Renaissance Capital’s IPO news (Mar 2026), Prime Number Capital acted as a joint bookrunner on the deal (https://www.renaissancecapital.com/IPO-Center/News/97929/IPO-Robot-Chinese-AI-technology-developer-Xiao-I-prices-downsized-US-IPO-at).

Prime Number Capital — (Renaissance Capital profile, IPO page)

The Renaissance Capital firm profile for AIXI’s IPO again lists Prime Number Capital among the underwriters, confirming the firm’s role within a multi‑bank syndicate responsible for the offering mechanics and investor placement (Renaissance Capital IPO profile for AIXI, accessed Mar 2026: https://www.renaissancecapital.com/Profile/AIXI/Xiao-I/IPO).

AC Sunshine Securities — (Renaissance Capital profile, IPO page)

AC Sunshine Securities is named in the underwriter roster on the Renaissance Capital IPO profile, indicating participation in distribution or underwriting support for the U.S. listing rather than an ongoing operational supplier relationship (Renaissance Capital IPO profile for AIXI, accessed Mar 2026: https://www.renaissancecapital.com/Profile/AIXI/Xiao-I/IPO).

SBI China Capital — (Renaissance Capital profile, IPO page)

SBI China Capital appears in the underwriter list on the same Renaissance Capital IPO profile, which places the firm within the syndicate that managed the offering and initial market placement for AIXI’s ADSs (Renaissance Capital IPO profile for AIXI, accessed Mar 2026: https://www.renaissancecapital.com/Profile/AIXI/Xiao-I/IPO).

Guotai Junan Securities — (Renaissance Capital news, March 2026)

Guotai Junan Securities acted as a joint bookrunner alongside Prime Number Capital, taking a lead role in underwriting AIXI’s U.S. offering and influencing deal pricing and allocation strategy (Renaissance Capital IPO news, Mar 2026: https://www.renaissancecapital.com/IPO-Center/News/97929/IPO-Robot-Chinese-AI-technology-developer-Xiao-I-prices-downsized-US-IPO-at).

Guotai Junan Securities — (Renaissance Capital profile, IPO page)

Guotai Junan is also specifically listed in the Renaissance Capital IPO profile as one of the underwriters, reinforcing its syndicate position and the cross‑border capital markets linkage that underpins AIXI’s U.S. listing status (Renaissance Capital IPO profile for AIXI, accessed Mar 2026: https://www.renaissancecapital.com/Profile/AIXI/Xiao-I/IPO).

What these relationships imply for operators and investors

The public record for AIXI’s supplier/partner history is concentrated entirely in underwriting and capital markets relationships tied to the company’s U.S. IPO. That concentration says three things about operating model and supplier posture:

  • Contracting posture: The visible suppliers are investment banks and securities firms engaged in a discrete capital markets contract (underwriting). This is a transaction‑focused posture rather than long‑term vendor dependency; the relationship is important for liquidity and narrative but not for daily operations.
  • Concentration and criticality: Supplier exposure is concentrated in a small underwriting syndicate. For ongoing operations, criticality is low — these firms provided capital markets services, not core software components or cloud infrastructure. For strategic risk, the underwriting group is critical only for listing, credibility, and potential follow‑on financing.
  • Maturity and supplier sophistication: The mix includes both regional Chinese securities houses and specialist underwriters, which is consistent with a cross‑border IPO strategy reliant on banks that can handle both domestic Chinese distribution and U.S. investor placement.

Company‑level financial signals reinforce the supplier narrative: market capitalization is small (≈$10.8M), revenue TTM ~$70.3M with negative EBITDA and EPS (-1.68), and a high beta (2.02). Those metrics indicate a capital‑dependent, early commercial maturity profile where relationships that enable financing and market access are material to strategic continuity.

For a drilldown on counterparty concentration analytics specific to AIXI’s underwriters, check the platform at https://nullexposure.com/.

Risk / opportunity checklist for counterparties and investors

  • Risk — financing reliance: With negative profitability and small market cap, AIXI is dependent on capital markets access; the underwriting pool’s willingness to support follow‑on raises is a strategic risk.
  • Risk — limited disclosure window: The public relationship trail is derived from IPO disclosures; there is limited visibility into long‑term supplier contracts for hosting, R&D, or enterprise implementation.
  • Opportunity — targeted partner strategy: The presence of both domestic and cross‑border banks suggests management pursued an investor base that can support China‑facing enterprise AI growth and international capital access.

Bottom line and next steps

Xiao‑I’s public supplier footprint is narrowly defined around IPO underwriters; for investors, the operative question is capital access rather than vendor concentration. Evaluate AIXI through the lens of financing runway and customer contract durability rather than traditional supplier dependency.

If you want a systematic view of counterparty exposure and underwriting concentration across Chinese tech issuers, start your research at https://nullexposure.com/. For a bespoke briefing on AIXI’s supplier network and financing counterparties, visit https://nullexposure.com/ to request a tailored analysis.